Mark Menard

Senior Medical Science Liaison at OSI Pharmaceuticals, LLC - Northbrook, IL, US

Mark Menard's Colleagues at OSI Pharmaceuticals, LLC
Jeannie Zerdes

Executive Representative - Hematology/Oncology

Contact Jeannie Zerdes

Marco De

Principal Scientist

Contact Marco De

Samantha Dougherty

Quality Control Research Associate II

Contact Samantha Dougherty

Beth Anderson

Senior Executive Hospital Representative

Contact Beth Anderson

Trey Howell

Executive Representative II - Specialty

Contact Trey Howell

View All Mark Menard's Colleagues
Mark Menard's Contact Details
HQ
800-888-7704
Location
Downingtown, Pennsylvania, United States
Company
OSI Pharmaceuticals, LLC
Mark Menard's Company Details
OSI Pharmaceuticals, LLC logo, OSI Pharmaceuticals, LLC contact details

OSI Pharmaceuticals, LLC

Northbrook, IL, US • 5000 - 9999 Employees
Major Drugs

Astellas Pharma US, Inc. is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Located in Northbrook, Illinois, the company serves as the headquarters for the Americas and employs nearly 3,000 people. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.

Pharmaceutical Drug Development And Manufacturing Healthcare Biotechnology Pharmaceutical Research Prescription Drug Medicine Medical Research Pharmaceutical Industries Pharmaceuticals
Details about OSI Pharmaceuticals, LLC
Frequently Asked Questions about Mark Menard
Mark Menard currently works for OSI Pharmaceuticals, LLC.
Mark Menard's role at OSI Pharmaceuticals, LLC is Senior Medical Science Liaison.
Mark Menard's email address is ***@astellas.com. To view Mark Menard's full email address, please signup to ConnectPlex.
Mark Menard works in the Major Drugs industry.
Mark Menard's colleagues at OSI Pharmaceuticals, LLC are Jeannie Zerdes, Marco De, Samantha Dougherty, Maureen O'Neill, Beth Anderson, Trey Howell, Dawnmarie Collins and others.
Mark Menard's phone number is 800-888-7704
See more information about Mark Menard